Experiences and Preferences of Opioid-Use-Disorder Patients Who Switched from Brand to Generic Buprenorphine/Naloxone Films: A Case Series

PURPOSE: Differences in the suppression of withdrawal symptoms have been observed in opioid-use-disorder (OUD) patients who were switched from Suboxone (the brand name of buprenorphine/naloxone sublingual films) to either 1 of 2 generic versions. These descriptive observations evidence the need to f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cedeño, Erica, Cruz, Ambar, Cortés, Joaris, Melin, Kyle, Roman, Luis, Gonzalez, Angel, Duconge, Jorge, Santiago, Darlene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761029/
https://www.ncbi.nlm.nih.gov/pubmed/35046643
http://dx.doi.org/10.2147/PPA.S336155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761029/
https://www.ncbi.nlm.nih.gov/pubmed/35046643
http://dx.doi.org/10.2147/PPA.S336155

Ejemplares similares